Julianne G Schultz
Overview
Explore the profile of Julianne G Schultz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
19
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robesti D, Nocera L, Belladelli F, Schultz J, Fallara G, Marandino L, et al.
BJU Int
. 2023 Jul;
133(2):158-168.
PMID: 37422731
Objective: To investigate the association between immune-related adverse events (irAEs) and oncological outcomes in patients with advanced urothelial cancer receiving immune checkpoint inhibitors (ICIs), and whether the administration of systemic...
2.
Martini A, Raggi D, Fallara G, Nocera L, Schultz J, Belladelli F, et al.
Cancer Treat Rev
. 2022 Feb;
104:102360.
PMID: 35176685
Background: Pembrolizumab and atezolizumab have recently been approved for the first-line treatment of patients with advanced urothelial carcinoma (aUC) who are not eligible for cisplatin-based chemotherapy and whose tumors have...
3.
Martini A, Afferi L, Zamboni S, Schultz J, Lonati C, Mattei A, et al.
J Urol
. 2021 May;
206(4):885-893.
PMID: 34032498
Purpose: Presently, major guidelines do not provide specific recommendations on oncologic surveillance for patients who harbor variant histology (VH) bladder cancer (BCa) at radical cystectomy. We aimed to create a...
4.
Chatrath A, Soldozy S, Sokolowski J, Burke R, Schultz J, Rannigan Z, et al.
World Neurosurg
. 2020 Jul;
142:e494-e501.
PMID: 32693223
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a debilitating disease process accounting for 5% of strokes. Although improvements in care have reduced the case-fatality rates, patients have an increased risk of...